Opportunities and Challenges for the Development and Adoption of Multicancer Detection Tests

The development of minimally invasive approaches to screen for multiple tumor types at one time could potentially improve health outcomes; however, the clinical utility of multicancer detection (MCD) testing has yet to be established. The National Academies National Cancer Policy Forum held a workshop in October 2024 to explore the current scientific understanding and clinical use of MCD testing, as well as implications for cancer care and outcomes for all patients.